Itonic Holdings Ltd. (NASDAQ:ITOC) Sees Large Decrease in Short Interest

Itonic Holdings Ltd. (NASDAQ:ITOC) saw a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 197,966 shares, a drop of 33.7% from the May 14th total of 298,627 shares. Based on an average trading volume of 48,103 shares, the short-interest ratio is currently 4.1 days. Approximately 1.2% of the shares of the company are sold short.

Itonic Stock Down 3.0%

ITOC stock opened at $0.33 on Tuesday. Itonic has a one year low of $0.25 and a one year high of $32.00. The stock has a fifty day moving average price of $0.32.

Itonic (NASDAQ:ITOC) last released its earnings results on Monday, March 30th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.23 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Itonic from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, June 5th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.